120 related articles for article (PubMed ID: 17668794)
21. The pharmaceutical situation in the Philippines.
Hartigan-Go K
Aust Health Rev; 2001; 24(2):25-31. PubMed ID: 11496467
[No Abstract] [Full Text] [Related]
22. Value-Based Pharmaceutical Contracts: Value for Whom?
Kannarkat JT; Good CB; Parekh N
Value Health; 2020 Feb; 23(2):154-156. PubMed ID: 32113619
[TBL] [Abstract][Full Text] [Related]
23. [The costs of new drugs compared to current standard treatment].
Ujeyl M; Schlegel C; Gundert-Remy U
Z Evid Fortbild Qual Gesundhwes; 2013; 107(7):461-7. PubMed ID: 24238023
[TBL] [Abstract][Full Text] [Related]
24. [No funds for contract physicians and drugs. However, deceased mental healers fill the cash registers].
Rautenstrauch J
MMW Fortschr Med; 2000 Nov; 142(47):4-5. PubMed ID: 11143779
[No Abstract] [Full Text] [Related]
25. [Pharmacists want to assume penalty].
MMW Fortschr Med; 2006 May; 148(20):55. PubMed ID: 16805194
[No Abstract] [Full Text] [Related]
26. [Declining costs].
Neumaier J
MMW Fortschr Med; 2016 Jun; 158 Suppl 1():58. PubMed ID: 27259908
[No Abstract] [Full Text] [Related]
27. Propaganda or the cost of innovation? Challenging the high price of new drugs.
Ghinea N; Lipworth W; Kerridge I
BMJ; 2016 Mar; 352():i1284. PubMed ID: 26968991
[No Abstract] [Full Text] [Related]
28. Pharmacy benefit manager 'spread': a reasonable, rational, realistic business practice.
Latanich T
J Am Pharm Assoc (2003); 2004; 44(1):10-1. PubMed ID: 14965146
[No Abstract] [Full Text] [Related]
29. The impact of physician-level drug budgets on prescribing behavior.
Fischer KE; Koch T; Kostev K; Stargardt T
Eur J Health Econ; 2018 Mar; 19(2):213-222. PubMed ID: 28194534
[TBL] [Abstract][Full Text] [Related]
30. [Incentives for especially cost effective prescribing. The physician protects his budget, the patient saves co-pay].
Schmidt K
MMW Fortschr Med; 2006 Nov; 148(44):57, 59. PubMed ID: 17619443
[No Abstract] [Full Text] [Related]
31. [[Prescriptions for psychotropic drugs: results and comments on the 2007 prescription drug report].
Fritze J
Nervenarzt; 2008 Nov; 79(11):1337-45. PubMed ID: 19002733
[No Abstract] [Full Text] [Related]
32. [Prescriptions for psychotropic drugs: results and comments on the 2005 prescription drug report].
Fritze J
Nervenarzt; 2006 Mar; 77(3):376-83. PubMed ID: 17078120
[No Abstract] [Full Text] [Related]
33. [Direct purchase of expensive medicine from the manufacturer may be required].
Zimmermann GW
MMW Fortschr Med; 2015 Jun; 157(11):12. PubMed ID: 26049324
[No Abstract] [Full Text] [Related]
34. [Decreased need for tablets with pantoprazole. PPI: independent study questions savings through use of generic drugs].
MMW Fortschr Med; 2007 Dec; 149(49-50):58. PubMed ID: 18236985
[No Abstract] [Full Text] [Related]
35. Generics vs. patent drugs: a very Canadian debate, eh?
Page B
Can Oncol Nurs J; 1998 Feb; 8(1):2. PubMed ID: 9677919
[No Abstract] [Full Text] [Related]
36. [Health care too costly? Saving more than 10 million euros in 2 months!].
Rappert B
MMW Fortschr Med; 2003 Nov; 145(47):65. PubMed ID: 14725043
[No Abstract] [Full Text] [Related]
37. Drugs: budget busters or cost cutters in future health care?
Egger E
Health Care Strateg Manage; 1999 Mar; 17(3):1, 22-3. PubMed ID: 10351640
[No Abstract] [Full Text] [Related]
38. Drifting policies are wasting billions.
Suh GH
Int Psychogeriatr; 2012 Mar; 24(3):343-5. PubMed ID: 22078134
[No Abstract] [Full Text] [Related]
39. [Medication supply of privately insured patients in 2010].
Wild F
Versicherungsmedizin; 2012 Jun; 64(2):85-6. PubMed ID: 22808648
[No Abstract] [Full Text] [Related]
40. Getting real about valuations in biotech.
Villiger R; Bogdan B
Nat Biotechnol; 2005 Apr; 23(4):423-8. PubMed ID: 15815665
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
